NIDDK Home : Research Funding : NIDDK SBIR/STTR program

NIDDK SBIR / STTR Program

  • Current Initiatives
  • Archived Initiatives
  • SBIR/STTR Program
  • Small Business Innovation Research (SBIR)
  • Small Business Technology Transfer (STTR)
  • SBIR/STTR Research Topics
  • Additional Information

    Small Business Innovation Research (SBIR)

    The NIH SBIR program is intended to support innovative research, conducted by small business concerns, which has the potential for commercialization. The program is designed in a two-step fashion where applicants submit a feasibility, or Phase I, application that is peer-reviewed. Typically these applications seek up to $100,000 for 6 months of research support. Successful recipients of Phase I funds may then submit Phase II applications, for both a longer duration (usually 2 years) and a larger amount (usually up to $750,000)of support. The funds for this program are 'set-aside' and therefore do not compete with the regular research, training, or other special programs supported by the Institutes.

    ALL National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) grant applicants are REQUIRED to submit applications online to the NIH through Grants.gov (http://www.grants.gov/) using the SF424 Research and Research Related (R&R) form as of the December 1, 2005, submission date (as announced in http://grants.nih.gov/grants/guide/notice-files/NOT-OD-05-067.html).

    [Top]

    Small Business Technology Transfer (STTR)

    The NIH STTR program is similar to the SBIR, but requires that the small business concern partner with a research institution to perform the project that will lead to a commercial product.

    The major differences between the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR) program are itemized below. This list is meant to provide you with enough information to help you decide to which program you should apply. Consultation with program staff is always encouraged if questions arise.

    • The set-aside for the SBIR program is 2.5% of the extramural budget; the set-aside for the STTR program is 0.15% of the extramural budget.

    • In Phase I SBIR grants, a minimum of 2/3 of the work MUST be performed by the small business concern; in Phase I STTR grants, a minimum of 40% of the work MUST be performed by the small business concern AND a minimum of 30% MUST be performed by the research institution.

    • In Phase II SBIR grants, a minimum of 50% of the work MUST be performed by the small business concern; in phase II STTR grants, the same requirements as Phase I grants must be followed, i.e. a minimum of 40% of the work MUST be performed by the small business, a minimum of 30% by the research institution.

    • For SBIR grants, the Principal Investigator must have his/her primary employment with the small business concern; for STTR grants, someone at either the small business concern or the research institution may be the P.I.

    • SBIR/STTR Application Instructions (PDF) | Forms

    • Federal Financial and Business Management Systems Requirement - Sample Policies and Procedures
    [Top]

    SBIR/STTR Research Topics

    Refer to the NIDDK Current Initiatives for SBIR and STTR initiative listings.

    SBIR/STTR research topics are listed in the NIDDK section of the NIH Omnibus Solicitation (PDF).

    [Top]

    Additional Information

    Applications may be submitted for any of the yearly receipt dates of April 1, August 1, and December 1.

    For more information, contact your NIDDK Program Director:

    DIABETES, ENDOCRINOLOGY AND METABOLIC DISEASES
    Diabetes Complications, Interventions and Therapies
    Dr. Teresa Jones
    (301) 435-2996 FAX: (301) 480-3503 Email: jonest@extra.niddk.nih.gov
    Sensors/Delivery Devices and Screening, Diagnostics and Biologic Tools
    Dr. Karen Teff
    (301) 594-8817 FAX: (301) 480-3503
    Email: teffk@niddk.nih.gov
    Islet Transplantation and Drug Development
    Dr. Guillermo Arreaza-Rubin
    (301) 594-8813 FAX: (301) 480-3510
    Email: arreazag@mail.nih.gov
    Diabetes Behavioral Therapy and Prevention
    Dr. Sanford Garfield
    (301) 594-8803 Fax: (301) 480-6271
    Email: garfields@extra.niddk.nih.gov
    Gene Therapy, Metabolic Diseases, and Cystic Fibrosis
    Dr. Catherine McKeon
    (301) 594-8810 Fax: (301) 480-3503
    Email: mckeonc@niddk.nih.gov
    Proteomics and Metabolic Profiling
    Dr. Salvatore Sechi
    (301) 594-8814 Fax: (301) 480-3503
    Email: sechis@niddk.nih.gov
    DIGESTIVE DISEASES AND NUTRITION
    Christine Densmore
    (301) 402-8714
    FAX (301) 480-8300
    Email: DensmoreC@extra.niddk.nih.gov
     
    KIDNEY, UROLOGIC AND HEMATOLOGIC DISEASES
    Kidney
    Dr. Robert A. Star
    (301) 594-7717 Fax: (301) 480-3510
    Email: rs301p@nih.gov
    Urology
    Dr. Leroy M. Nyberg
    (301) 594-7717 Fax: (301) 480-3510
    Email: ln10f@nih.gov
    Hematology
    Dr. David G. Badman
    (301) 594-7717 Fax: (301) 480-3510
    Email: db70f@nih.gov
     


    For administrative and business management questions, contact:

    Mrs. Helen Ling
    Grants Management Specialist
    National Institute of Diabetes and Digestive and Kidney Diseases
    Democracy 2, Room 732
    phone: (301) 594-8857;
    Fax: (301) 480-3504;
    email: lingh@extra.niddk.nih.gov

    Last Updated: 10/20/2005 [Top]
  • General inquiries may be addressed to: Office of Communications & Public Liaison
    NIDDK, NIH
    Building 31. Rm 9A06
    31 Center Drive, MSC 2560
    Bethesda, MD 20892-2560
    USA